Expression analyses utilizing microarray platforms, qPCR studies and IHC analyses have revealed that Cks1 is overexpressed in different subtypes of lymphoma including mantle cell lymphoma (MCL) and mantle cell lymphoma blastoid variant (MCL-BV), and contributes to development of disease and resistance to cancer chemotherapy [121–124]. This evidence concerns the gene CKS1B and mantle cell lymphoma.